The global biological indicator vial market size is estimated to stand at US$ 163.3 million in 2024. The market valuation is projected to surpass US$ 265.9 million by 2034, registering an average CAGR of 5.0%.
Key Highlights
Attributes | Details |
---|---|
Biological Indicator Vial Market Size (2024) | US$ 163.3 million |
Biological Indicator Vial Market Forecasted Size (2034) | US$ 265.9 million |
Projected Value CAGR (2024 to 2034) | 5.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Biological Indicator Vials Shine in Strict Industry Standards! The growing reliance on biological indicator vials stems from their assurance in validating sterilization procedures' effectiveness.
Technological Advances Fuel Unprecedented Growth! Technological developments are one of the primary variables driving the growth of the biological indicator vial market.
Biological Indicator Vials Ride High on the Surge in Sterilization Requirements! The growing requirement for dependable sterilization techniques is another factor driving the market.
Biological Indicator Vials Ride the Wave of Healthcare Evolution! Biological indicator incubator market growth continues to be aided by current developments in the healthcare industry.
As people become more aware of the negative repercussions of using ethylene oxide, sales of biological indicator vials are likely to decline. Exposure to ethylene oxide, in particular, harms individuals' well-being. It can lead to irritation to the skin, induce cyanosis, breathing problems, lung damage, nausea, vomiting, headaches, and diarrhea.
The demand for biological indicator vials is constrained by flawed sterilization equipment, non-compliance with biotechnology sterilization criteria, and high instrument costs. Challenges such as chemical exposure, difficulty in identifying procedural issues, and complex package configurations in the load contribute to limiting the adoption of these vials.
From 2019 to 2023, the global biological indicator vial industry showed healthy growth, boasting a 3.0% CAGR. The sector has grown significantly over this period because of the growing commercialization of parenteral treatments, enhanced product development, and the growing usage of universal sterilization indicators.
Historical CAGR (2019 to 2023) | 3.0% |
---|---|
Forecasted CAGR (2024 to 2034) | 5.0% |
Given the increased frequency of surgical site infections and the subsequent demand for hospital-acquired infection prevention approaches, the market for biological indicator vials is expected to grow gradually over the forecast period. As awareness of biological indicator vial’s ability to stop infections in hospitals has grown, so has the rise in sales.
Several technological advances and new product innovations are occurring in this industry. This gives players the opportunity to develop fresh and inventive products. The time it takes to read pharmaceutical sterilization indicators has improved with the introduction of fluorescence reading technology (BIs). With a 15-minute reading, the STERRAD VELOCITY™ System is the quickest BI available. At the same time, human tissues can be firmly contacted by flexible bioelectronics technology, which lessens incursion and increases the precision of monitored signals.
Attributes | Details |
---|---|
Trends |
|
Opportunities |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The biological indicator vial market, the biological and chemical indicator market, and the sterilization equipment market share a common foundation within the broader life sciences and healthcare domain. Each addresses separate aspects that contribute to the overall well-being of individuals and the advancement of medical science.
As per the provided table, from 2024 to 2034, the biological indicator vial market is likely to exhibit a relatively lower CAGR than the other two markets. However, the biological indicator vial industry seems to have a bright future and is projected to continue growing.
Biological Indicator Vial Market:
Differentiating Aspects | Biological Indicator Vial Market |
---|---|
CAGR (2024 to 2034) | 5.0% |
Projected Market Value by 2034 | US$ 265.9 million |
Growth Factor | Stringent regulations and guidelines promoting the use of biological indicators |
Opportunity | Development of innovative biological indicators for diverse applications |
Key Trend | Customization of biological indicators based on specific industry needs |
Biological and Chemical Indicator Market:
Differentiating Aspects | Biological and Chemical Indicator Market |
---|---|
CAGR (2024 to 2034) | 5.9% |
Projected Market Value by 2034 | US$ 921.12 million |
Growth Factor | Growing demand for sterilization processes in pharmaceuticals and biotechnology |
Opportunity | Development of customized chemical indicators for specialized sterilization needs |
Key Trend | Shift toward environmentally friendly and sustainable biological indicators |
Sterilization Equipment Market:
Differentiating Aspects | Sterilization Equipment Market |
---|---|
CAGR (2024 to 2034) | 8.3% |
Projected Market Value by 2034 | US$ 37.22 billion |
Growth Factor | An increased focus on infection prevention and hygiene in healthcare |
Opportunity | Adoption of advanced sterilization technologies like ozone sterilization |
Key Trend | Incorporating robots and automation into sterilizing procedures |
North America stands out as a dominant force in the biological indicator vial industry because of stringent regulations in the healthcare sector. The market in Europe is growing steadily. An increasing focus on patient safety and infection control solutions is boosting product adoption. Meanwhile, the Asia Pacific biological indicator vials market is set to experience rapid growth, given its developing healthcare infrastructures.
Countries | Forecasted CAGR (2024 to 2034) |
---|---|
China | 5.7% |
France | 3.2% |
Japan | 2.9% |
United States | 2.5% |
Germany | 2.1% |
Adoption of biological indicator vial in China is likely to exhibit a CAGR of 5.7% through 2034. Reasons supporting this rapid adoption include:
The France biological indicator vial market is forecasted to inflate at a CAGR of 3.2% through 2034. The top aspects supporting the market growth are:
The Japan biological indicator vial market is expected to surge at a CAGR of 2.9% through 2034. Top factors supporting the market expansion include:
Demand for biological indicator vials in the United States is rising with an anticipated CAGR of 2.5% through 2034. Key factors influencing the demand include:
Sales of biological indicator vials in Germany are estimated to record a CAGR of 2.1% through 2034. Key variables backing up this phenomenon are:
As far as the sterilization type is concerned, the steam sterilization segment is likely to dominate the industry in 2024, accounting for a 56.8% market share. Similarly, the pharmaceutical segment is expected to take the lead when considering end use, commanding a 65.1% biological indicator vial market share in 2024.
Segment | Market Share in 2024 |
---|---|
Steam Sterilization | 56.8% |
Pharmaceutical | 65.1% |
Steam sterilization is becoming increasingly preferred across industries. The following elements contribute to the dominance:
The pharmaceutical industry is set to take the biological indicator vial market by storm. Factors supporting this supremacy include:
Businesses compete for supremacy in the ever-changing biological indicator vial market by strategically integrating modern technologies, maintaining strict quality control, and providing attentive customer service. Investments in research and development fuel new product creation. Strategic collaborations and global market penetration alter the competitive environment, encouraging growth and resilience.
Key Product Developments
The biological indicator vial industry is forecasted to be valued at US$ 163.3 million in 2024.
The biological indicator vial industry is projected to surpass US$ 265.9 million by 2034.
The CAGR of the biological indicator vial industry is estimated to be around 5.0% through 2034.
3M Company, VWR Corporation, and STERIS plc. are biological indicator vial industry leaders.
China, Japan, France, and the United States are key consumers of biological indicator vial.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Incubation Time 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Incubation Time, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Incubation Time, 2024 to 2034 5.3.1. Up to 24 hours 5.3.2. 24 to 32 hours 5.3.3. 32 to 48 hours 5.3.4. Above 48 hours 5.4. Y-o-Y Growth Trend Analysis By Incubation Time, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Incubation Time, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sterilization Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Sterilization Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Sterilization Type, 2024 to 2034 6.3.1. Steam Sterilization 6.3.2. Ethylene Oxide Sterilization 6.4. Y-o-Y Growth Trend Analysis By Sterilization Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Sterilization Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2024 to 2034 7.3.1. Food & Beverages 7.3.2. Pharmaceutical 7.3.3. Cosmetics 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By End Use, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End Use, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Incubation Time 9.2.3. By Sterilization Type 9.2.4. By End Use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Incubation Time 9.3.3. By Sterilization Type 9.3.4. By End Use 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Incubation Time 10.2.3. By Sterilization Type 10.2.4. By End Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Incubation Time 10.3.3. By Sterilization Type 10.3.4. By End Use 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Incubation Time 11.2.3. By Sterilization Type 11.2.4. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Incubation Time 11.3.3. By Sterilization Type 11.3.4. By End Use 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Incubation Time 12.2.3. By Sterilization Type 12.2.4. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Incubation Time 12.3.3. By Sterilization Type 12.3.4. By End Use 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Incubation Time 13.2.3. By Sterilization Type 13.2.4. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Incubation Time 13.3.3. By Sterilization Type 13.3.4. By End Use 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Incubation Time 14.2.3. By Sterilization Type 14.2.4. By End Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Incubation Time 14.3.3. By Sterilization Type 14.3.4. By End Use 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Incubation Time 15.2.3. By Sterilization Type 15.2.4. By End Use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Incubation Time 15.3.3. By Sterilization Type 15.3.4. By End Use 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Incubation Time 16.1.2.2. By Sterilization Type 16.1.2.3. By End Use 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Incubation Time 16.2.2.2. By Sterilization Type 16.2.2.3. By End Use 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Incubation Time 16.3.2.2. By Sterilization Type 16.3.2.3. By End Use 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Incubation Time 16.4.2.2. By Sterilization Type 16.4.2.3. By End Use 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Incubation Time 16.5.2.2. By Sterilization Type 16.5.2.3. By End Use 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Incubation Time 16.6.2.2. By Sterilization Type 16.6.2.3. By End Use 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Incubation Time 16.7.2.2. By Sterilization Type 16.7.2.3. By End Use 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Incubation Time 16.8.2.2. By Sterilization Type 16.8.2.3. By End Use 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Incubation Time 16.9.2.2. By Sterilization Type 16.9.2.3. By End Use 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Incubation Time 16.10.2.2. By Sterilization Type 16.10.2.3. By End Use 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Incubation Time 16.11.2.2. By Sterilization Type 16.11.2.3. By End Use 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Incubation Time 16.12.2.2. By Sterilization Type 16.12.2.3. By End Use 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Incubation Time 16.13.2.2. By Sterilization Type 16.13.2.3. By End Use 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Incubation Time 16.14.2.2. By Sterilization Type 16.14.2.3. By End Use 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Incubation Time 16.15.2.2. By Sterilization Type 16.15.2.3. By End Use 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Incubation Time 16.16.2.2. By Sterilization Type 16.16.2.3. By End Use 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Incubation Time 16.17.2.2. By Sterilization Type 16.17.2.3. By End Use 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Incubation Time 16.18.2.2. By Sterilization Type 16.18.2.3. By End Use 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Incubation Time 16.19.2.2. By Sterilization Type 16.19.2.3. By End Use 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Incubation Time 16.20.2.2. By Sterilization Type 16.20.2.3. By End Use 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Incubation Time 16.21.2.2. By Sterilization Type 16.21.2.3. By End Use 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Incubation Time 16.22.2.2. By Sterilization Type 16.22.2.3. By End Use 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Incubation Time 16.23.2.2. By Sterilization Type 16.23.2.3. By End Use 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Incubation Time 17.3.3. By Sterilization Type 17.3.4. By End Use 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. 3M 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. STERIS 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Siltex Australia 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. CertoClav Sterilizer 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Mesa Labs 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Thermo Fisher Scientific 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. ParaSure 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Halma 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. VWR Corporation 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
September 2020
REP-GB-12544
March 2023
333 pages
Explore Packaging Insights
View Reports